Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimulants for cognitive enhancement in healthy Soldiers
NCT03893032Phase 2Unknown
- Sponsor
- United States Army Aeromedical Research Laboratory
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of modafinil and dextroamphetamine + amphetamine, sponsored by United States Army Aeromedical Research Laboratory. Primary endpoint: Working memory performance at 2 hours. Status: unknown.
02
Drugs
modafinildextroamphetamine + amphetamine
Beyond the preview
Go deeper on NCT03893032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893032.